Combined amivantamab, lazertinib, and bevacizumab in patients with EGFR-mutant advanced non-small-cell lung cancer with acquired resistance to a third-generation EGFR tyrosine-kinase inhibitor (ETOP 18-21 AMAZE-lung): a prospective, international, multicentre, single-arm, phase 2 trial
Ross Andrew Soo,Sanjay Popat,Urania G. Dafni,Adrianus Johannes De Langen,Ernest Nadal,Patricia Iranzo,Martin Früh,Maurice Pérol,Giulio Metro,Maria Angeles Sala,Marc Cucurull Salamero,Ferdinando Cerciello,Alfredo Addeo,Manuel Dómine,Youssef Oulkhouir,Nicolas Cloarec,Rafael López Castro,Patrizia Froesch,Heidi Roschitzki‐Voser,Barbara Ruepp
PDF的下载单位、IP信息已删除
(2025-6-4)
秋风
无极微光
DW
林狗
学术文献互助
Nole
神勇映雁
aaaa
amorfati
xing_xing
我能私信骂你吗
XX
学霸业
极限001
GingerF
老胡
牧青
alqb
OK
Non
皖公网安备34019202002308
